Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Apr 22;2(1):6.
doi: 10.1186/1476-7961-2-6.

Circulating immune complexes and complement C3 and C4 levels in a selected group of patients with rhinitis in Lebanon

Alexander M Abdelnoor  1 , Firas Kobeissy, Daad Farhat, Usamah Hadi
Affiliations

Circulating immune complexes and complement C3 and C4 levels in a selected group of patients with rhinitis in Lebanon

Alexander M Abdelnoor et al. Clin Mol Allergy. .

Abstract

BACKGROUND: A number of reports indicate that circulating immune complexes (CIC) and activation of the complement system contribute to the pathogenesis of Type I allergy. The aim of this study was to investigate the status of CIC in 113 patients with rhinitis in Lebanon and determine complement components C3 and C4 serum levels in the CIC-positive patients. Serum specific IgE antibodies were previously detected and reported in 74 of the 113 patients. METHODS: CIC were detected by polyethylene glycol precipitation and serum C3 and C4 levels quantified by radial immunodiffusion. RESULTS: CIC was positive in 20 of the specific IgE-positive and 13 of the specific IgE-negative patients. C3 and C4 levels were within the normal range in all the 33 CIC-positive patients. CONCLUSIONS: The antibody class that constitutes the complexes does not seem to be IgG or IgM. Moreover, complement activation does not seem to be involved in the allergic reaction since both C3 and C4 levels were normal in all patients. The role of these complexes, if any, in the pathogenesis of rhinitis is yet to be determined.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Rosen F, Geha R. In Case Studies in Immunology. 3. New York, Garland Publishing; 2001. Allergic asthma; pp. 127–134.
    1. Nagata S, Glovsky M. Activation of human serum complement with allergens. J Allergy Clin Immunol. 1987;80:24–32. - PubMed
    1. Hidvegi T, Schmidt B, Varga L, Dervaderics M, Lantos A, Gonczi Z, Barok J, Otos M, Kirschfink M, Spath P, Fust G. In vitro complement activation by ragweed allergen extract in the sera of ragweed allergic and non-allergic persons. Immunol Lett. 1995;48:65–71. doi: 10.1016/0165-2478(95)02445-X. - DOI - PubMed
    1. Hidvegi T, Berrens L, Vaqra L, Maranon F, Schmidt B, Kirschfink M, Fust G. Comparative study of the complement-activating and specific IgE-binding properties of ragweed pollen allergen. Clin Exp Immunol. 1997;108:122–127. doi: 10.1046/j.1365-2249.1997.d01-974.x. - DOI - PMC - PubMed
    1. Gonczi Z, Varga L, Hidvegi T, Schmidt B, Panya A, Kokai M, Fust G. The severity of clinical symptoms in ragweed-allergic patients is related to the extent of ragweed-induced complement activation in their sera. Allergy. 1997;52:1110–1114. - PubMed

LinkOut - more resources